Walter S. Tomenson - 20 May 2022 Form 4 Insider Report for PSYCHEMEDICS CORP (PMDI)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
24 May 2022, 17:41:30 UTC
Prior SEC filing
14 May 2021
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Patrick J. Kinney, Jr. as attorney-in-fact for Walter S. Tomenson

Key filing fact

Walter S. Tomenson filed Form 4 for PSYCHEMEDICS CORP (PMDI) on 24 May 2022.

Key facts

  • This page summarizes Walter S. Tomenson's Form 4 filing for PSYCHEMEDICS CORP (PMDI).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 24 May 2022, 17:41.

Change

  • Previous filing in this sequence was filed on 14 May 2021.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PMD transaction

Common Stock, $.005 Par Value

Award

Transaction value
$0
Shares
+12,000
Change %
+19%
Price
$0.000000
Shares after
74,399
Date
20 May 2022
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents restricted stock units that are to be settled solely in shares of Common Stock. The units vest with respect to 50% of the shares on April 30, 2023 and with respect to the remaining 50% on April 30, 2024, so long as the recipient continues as a director of the Issuer through each such respective vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .